Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of NRL001 Cream in Healthy Volunteers
NCT06593730Phase 1Completed
- Sponsor
- Norgine
- Start
- Aug 2007
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of Methoxamine in fecal incontinence (FI) (7 arms), sponsored by Norgine. Primary endpoints: Recumbent and standing blood pressure and pulse rate at 17 days, Ambulatory 24 hour BP monitoring at 17 days and 2 more. Started Aug 2007; status: completed.
02
Drugs
Methoxamine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT06593730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06593730.